Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
LIXTE Biotechnology Reports Preclinical Results of Striking Anti-Cancer Activity of LB-100
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) reports that Professor René Bernards, Netherlands Cancer Institute, Amsterdam has presented new data from promising drug combinations of LIXTE’s lead clinical cancer compound,...